UNSPSC 51461550: Hippocastanum + sabal serrulata + solidago v.aurea extracts

Used in benign prostatic hyperplasia

UNSPSC 51461550 Hippocastanum + sabal serrulata + solidago v.aurea extracts, a Commodity code, covers botanical extract pharmaceutical products sourced through state and local cooperative purchasing vehicles for distribution to public health and institutional facilities. Based on recent solicitation activity, this code encompasses generic and over-the-counter pharmaceutical products supplied through authorized wholesale distribution channels, with vendors required to meet cGMP and Drug Supply Chain Security Act compliance, provide comprehensive product specifications including National Drug Codes and packaging configurations, and maintain contractual relationships with designated wholesaler networks. Issuing bodies under this code include state departments of administration, cooperative purchasing alliances spanning multiple states and local jurisdictions, and participating institutional healthcare facilities within those cooperative networks.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 effective date for awarded vendors. The procurement spans participating state and local government facilities across Minnesota and Oregon, with vendors required to supply products through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Evaluation weighted price competitiveness at 75 percent, with the remaining 25 percent divided among fixed pricing, administrative compliance, EDI capability, and the 3 percent administrative fee requirement. All products must be available by May 15, 2026, with contract terms of two years for new vendors and optional extensions at MMCAP's discretion, while incumbent vendors' amendments extend through June 30, 2028.